This, in turn, facilitates the activation of transient receptor potential vanilloid (TRPV) and calcium release activated calcium current (CRAC) channels and enhances calcium influx through the plasma membrane in several cell types, including cancer cells and immune cells, where KCa3.1 is expressed (Feske et al. 2019, 2015). The gene discussed is KCNN4; the disease is cancer.